Literature DB >> 17596887

Sodium retention and ascites formation in a cholestatic mice model: role of aldosterone and mineralocorticoid receptor?

Daniel Ackermann1, David Mordasini, Lydie Cheval, Martine Imbert-Teboul, Bruno Vogt, Alain Doucet.   

Abstract

UNLABELLED: Renal sodium retention in experimental liver cirrhosis originates from the distal nephron sensitive to aldosterone. The aims of this study were to (1) determine the exact site of sodium retention along the aldosterone-sensitive distal nephron, and (2) to evaluate the role of aldosterone and mineralocorticoid receptor activation in this process. Liver cirrhosis was induced by bile duct ligation in either adrenal-intact or corticosteroid-clamped mice. Corticosteroid-clamp was achieved through adrenalectomy and corticosteroid supplementation with aldosterone and dexamethasone via osmotic minipumps. 24-hours renal sodium balance was evaluated in metabolic cages. Activity and expression of sodium- and potassium-dependent adenosine triphosphatase were determined in microdissected segments of nephron. Within 4-5 weeks, cirrhosis induced sodium retention in adrenal-intact mice and formation of ascites in 50% of mice. At that time, sodium- and potassium-dependent adenosine triphosphatase activity increased specifically in cortical collecting ducts. Hyperaldosteronemia was indicated by increases in urinary aldosterone excretion and in sgk1 (serum- and glucocorticoid-regulated kinase 1) mRNA expression in collecting ducts. Corticosteroid-clamp prevented induction of sgk1 but not cirrhosis-induced sodium retention, formation of ascites and stimulation of sodium- and potassium-dependent adenosine triphosphatase activity and expression (mRNA and protein) in collecting duct. These findings demonstrate that sodium retention in cirrhosis is independent of hyperaldosteronemia and of the activation of mineralocorticoid receptor.
CONCLUSION: Bile duct ligation in mice induces cirrhosis which, within 4-5 weeks, leads to the induction of sodium- and potassium-dependent adenosine triphosphatase in cortical collecting ducts, to renal sodium retention and to the formation of ascites. Sodium retention, ascites formation and induction of sodium- and potassium-dependent adenosine triphosphatase are independent of the activation of mineralocorticoid receptors by either aldosterone or glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596887     DOI: 10.1002/hep.21699

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  SGK, renal function and hypertension.

Authors:  Florian Lang; Dan Yang Huang; Volker Vallon
Journal:  J Nephrol       Date:  2010 Nov-Dec       Impact factor: 3.902

2.  ENaC activity in collecting ducts modulates NCC in cirrhotic mice.

Authors:  David Mordasini; Dominique Loffing-Cueni; Johannes Loffing; Rohrbach Beatrice; Marc P Maillard; Edith Hummler; Michel Burnier; Geneviève Escher; Bruno Vogt
Journal:  Pflugers Arch       Date:  2015-06-10       Impact factor: 3.657

Review 3.  ANP-induced signaling cascade and its implications in renal pathophysiology.

Authors:  Franziska Theilig; Qingyu Wu
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-28

Review 4.  Targeting SGK1 in diabetes.

Authors:  Florian Lang; Agnes Görlach; Volker Vallon
Journal:  Expert Opin Ther Targets       Date:  2009-11       Impact factor: 6.902

Review 5.  The physiological impact of the serum and glucocorticoid-inducible kinase SGK1.

Authors:  Florian Lang; Ferruh Artunc; Volker Vallon
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-09       Impact factor: 2.894

Review 6.  Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development.

Authors:  Bénédicte Delire; Peter Stärkel; Isabelle Leclercq
Journal:  J Clin Transl Hepatol       Date:  2015-03-15

7.  A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (-)-epigallocatechin-3-gallate.

Authors:  Xiaoxiao Wang; Lumin Yang; Jiajia Wang; Yafei Zhang; Ruixia Dong; Ximing Wu; Chung S Yang; Zhenhua Zhang; Jinsong Zhang
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.